title: [Treatment of rheumatoid arthritis (RA) with anticytokines].
abstract: In the hands of an experienced rheumatologist and in adherence to the contraindications named in the article, anticytokines such asTNF-alpha blockers or interleukin-1 antagonists are regarded as relatively reliable, are well tolerated and in many cases, are very effective. Especially when used in combination with methotrexate, they demonstratively lower the disease activity score and significantly slow the radiographic progression.Thus, anticytokines are currently the most effective therapy for RA. An additional advantage compared to conventional DMARD is the rapid onset of action (usually within two to four weeks).TNF-alpha blockers are also presently employed in numerous other chronic inflammatory diseases. The efficacy of anticytokines in psoriasis and psoriatic arthritis, ankylosing spondylitis, juvenile arthritis and Crohn's disease has been proven.
authors.affiliation: Medizinische Klinik mit Poliklinik II der Universität Würzburg. Feuchtenbe_M@klinik.uni-wuerzburg.de
authors.forename: M
authors.initials: M
authors.lastname: Feuchtenberger
authors.forename: C
authors.initials: C
authors.lastname: Kneitz
authors.forename: H P
authors.initials: HP
authors.lastname: Tony
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000276:immunology; D016207:Cytokines / Q000097:blood; D018450:Disease Progression; D006225:Hand / Q000000981:diagnostic imaging; D006801:Humans; D011859:Radiography; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha